Detalhe da pesquisa
1.
"Moderate" adjuvant chemotherapy-induced leukopenia is beneficial for survival of patients with early breast cancer: a retrospective study.
BMC Cancer
; 23(1): 1227, 2023 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38093246
2.
The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: a phase II, multicenter, single-arm study (SYSUCC-005).
BMC Cancer
; 22(1): 271, 2022 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35291977
3.
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.
JAMA
; 325(1): 50-58, 2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33300950
4.
Efficacy of Moxifloxacin plus Treatment of Physician's Choice in Patients with Metastatic Breast Cancer.
Oncologist
; 25(10): e1439-e1445, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32390277
5.
Effect of rituximab on adult Burkitt's lymphoma: a systematic review and meta-analysis.
Ann Hematol
; 95(1): 19-26, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26423805
6.
Effect of Adjuvant Metronomic Capecitabine on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer-Reply.
JAMA
; 325(17): 1793, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33944878
7.
Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma.
Ann Hematol
; 94(9): 1525-33, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25957850
8.
The extent of local tumor invasion predicts prognosis in stage IE nasal natural killer/T-cell lymphoma: a novel T staging system for risk stratification.
Ann Hematol
; 94(9): 1515-24, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25924921
9.
Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy.
Ann Hematol
; 94(7): 1175-84, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25687842
10.
Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP.
Ann Hematol
; 94(11): 1865-73, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26327569
11.
Screening optimal candidates with operable, early-stage triple-negative breast cancer benefitting from capecitabine maintenance: A post-hoc analysis of the SYSUCC-001 study.
Breast
; 76: 103740, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733700
12.
Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study.
Cancer Res Treat
; 56(2): 513-521, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846468
13.
Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasis.
NPJ Breast Cancer
; 10(1): 45, 2024 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38871705
14.
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.
Breast Cancer (Dove Med Press)
; 16: 223-231, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38628818
15.
NAD induces astrocyte calcium flux and cell death by ART2 and P2X7 pathway.
Am J Pathol
; 181(3): 746-52, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22781627
16.
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1).
Breast Cancer
; 30(3): 412-423, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689066
17.
What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database.
Cancer Med
; 12(12): 13019-13030, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096751
18.
The Iron-Inflammation Axis in Early-Stage Triple-Negative Breast Cancer.
Front Cell Dev Biol
; 10: 784179, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35281097
19.
Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study.
J Inflamm Res
; 15: 3957-3974, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35860229
20.
Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study.
J Oncol
; 2022: 7839041, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36245976